Health Condition 1: null- patients of metabolic syndrome fulfilling inclusion criteria and willing to participate in clinical trial
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Abdominal obesity, (waist circumference >90 cm in men and >80 cm in women) Hypertriglyceridaemia (S.Triglycerides level 150-600 mg/dl); Low HDL cholesterol (S.HDL cholesterol Elevated blood pressure (Systolic blood pressure 130-160 mmHg and/or diastolic blood pressure 85-100 mmHg); Impaired fasting glucose (Fasting plasma glucose 100-200 mg/dl).
Exclusion criteria
Exclusion criteria: • Age below 20 and above 60 years • Patients suffering from type 1 Diabetes mellitus and uncontrolled diabetes mellitus & uncontrolled hypertension • Drug induced & uncontrolled dyslipidemia • Systemic illness like Tuberculosis, Carcinoma and Endocrine disorders like Cushing syndrome, Hypothyroidism • Patient having the past history of M.I. & Unstable Angina. • Patient having Clinical Features of CCF • Patient having the major renal or liver disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that the trial drugs will exert a significant action on metabolic syndrome.Timepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| By providing better effect on metabolic syndrome, drug may also reduce the risk of diabetes, CVA and IHD.Timepoint: 8 weeks | — |
Countries
India
Contacts
Institute for post graduate teaching and research in Ayurveda Gujarat Ayurved University Jamnagar